Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

For some multiple myeloma patients, Carvykti cut risk of death by 45%

9 months ago

EnGene unveils first set of pivotal data for NMIBC therapy

9 months ago

Italian gene therapy startup nabs $52M for rare genetic disease that Moderna is working on

9 months ago

Updated: Gene therapy maker bluebird bio cuts costs again, lays off staff

9 months ago

4DMT's gene therapy reduced need for standard-of-care injections to treat age-associated vision loss

9 months ago

Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO

9 months ago

A new startup wants to fight cancer with 'off-the-shelf' gene therapy, securing $26M seed round

10 months ago

BridgeBio ends development of gene therapy for adrenal gland disorder

10 months ago

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

10 months ago

CBER chief forecasts better global regulatory convergence around cell and gene therapies

10 months ago

Biopharma companies, BARDA call for more clarity on FDA's new platform tech proposal

10 months ago

Former Regenxbio leaders take rare disease gene therapies to startup with $15M

10 months ago

Gene insertion startup Tome Biosciences stops lab work as CEO shifts focus to deal talks

10 months ago

Bluebird's slow sickle cell launch forces rework of loan, putting cash runway at risk

10 months ago

Avenge Bio, a cell therapy biotech from Rice, is closed

10 months ago

Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing

10 months ago

CSL Behring says uptake of hemophilia B gene therapy slower than expected

11 months ago

Legend continues Carvykti factory builds to cement CAR-T territory with J&J

11 months ago

FDA lifts hold on 4DMT's Fabry gene therapy

11 months ago

Florida CNS gene therapy biotech shuts down

11 months ago

Galapagos pauses blood cancer CAR-T therapy trial due to one Parkinsonism event

11 months ago

Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer

11 months ago

Vertex says about 20 patients have started sickle cell therapy, cuts two rare disease programs

11 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

11 months ago

First page Previous page 4 5 678 9 10 Next page Last page